Consistent with these data, recent reports support the hypothesis that mild disease is associated with mucosal-specific sIgA secretion (tears, nasal fluid, saliva), whereas systemic antibody titers, including serum IgA, correlate with severe COVID-19 [187]. Here, CD79A is linked to COVID-19.